糖尿病视网膜病变治疗覆盖范围的措施:方法论审查协议
Nimisha Chabba1, Pushkar Raj Silwal2, Covadonga Bascaran3
1School of Optometry and Vision Science, University of Auckland, Auckland, New Zealand nimisha.chabba@auckland.ac.nz.
BMJ open
|March 29, 2025
概括
本综述探讨了在研究中如何衡量糖尿病视网膜病变治疗覆盖率. 标准化定义对于比较糖尿病眼科护理质量和改善全球患者治疗结果至关重要.
科学领域:
- 眼科医生 眼科 眼科
- 公共卫生 公共卫生
- 医疗保健服务研究 医疗服务研究
背景情况:
- 糖尿病视网膜病变是全球视力障碍的主要原因之一.
- 有效的治疗启动和完成对于预防视力丧失至关重要.
- 对糖尿病视网膜病变的监测治疗覆盖范围比查更少,定义各不相同.
研究的目的:
- 总结一下已发表的研究中糖尿病视网膜病变治疗覆盖率是如何衡量的.
- 评估按人口群体对治疗覆盖率数据的分类程度.
- 确定对标准化定义的需求,以比较糖尿病眼部护理质量.
主要方法:
- 在Medline和Embase (从2015年开始) 进行系统的文献搜索.
- 包括队列和横截面研究,报告激光光凝,抗VEGF,皮质类固醇注射或玻璃切除术的治疗覆盖率.
- 使用PROGRESS框架来评估按人口群体进行数据分类.
主要成果:
- 对糖尿病视网膜病变治疗覆盖范围的定义和数据源的描述性综合.
- 确定治疗覆盖率如何定义和报告的变化.
- 在现有文献中评估基于人口的分类.
结论:
- 需要对糖尿病视网膜病变治疗覆盖范围的标准化定义.
- 改善治疗覆盖率的监测可以提高糖尿病眼睛护理质量.
- 调查结果将为糖尿病眼科护理途径的服务监测指标的开发提供信息.
相关概念视频
Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...


